Brazil Viscosupplementation Market Size & Outlook
Brazil viscosupplementation market, 2018-2030 (US$M)
Related Markets
Brazil viscosupplementation market highlights
- The Brazil viscosupplementation market generated a revenue of USD 35.1 million in 2023 and is expected to reach USD 70.6 million by 2030.
- The Brazil market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
- In terms of segment, three injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 35.1 million |
| Market revenue in 2030 | USD 70.6 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Three injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Brazil accounted for 0.7% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 18.5 million by 2030.
Three injection was the largest segment with a revenue share of 42.45% in 2023. Horizon Databook has segmented the Brazil viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
In Brazil, there are around 1.4 million women and 0.6 million men aged over 50 suffering from osteoporosis. According to International Osteoporosis Foundation, private insurers do not reimburse osteoporosis medications, whereas the government insurers reimburse some of the dispensed osteoporosis medications.
Growing life expectancy has increased healthcare burden of osteoarthritis, which is recognized as a public health problem. According to World Bank, the average life expectancy in Brazil is about 75.5 years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil viscosupplementation market size, by product, 2018-2030 (US$M)
Brazil Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
